Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Integer Holdings Corp.

https://integer.net

Latest From Integer Holdings Corp.

Series B Pumps $15m Into Abiomed-Backed Acute HF Start-Up

Magenta Medical Ltd, an Israeli start-up founded by cardiology veterans and backed by miniaturized heart pump specialist Abiomed, has reeled in $15m in Series B financing. The additional capital will enable the company to take its catheter-based therapy for acute heart failure through clinical trials and beyond CE-mark approval.

Cardiology Financing

Market Intel: Pain Management II: Competition Intensifies For Spinal Cord Stim Market's Big Three

In the global pain management market, spinal cord stimulation (SCS) systems are expected to continue to be the fastest-growing segment with increasing competition among device manufacturers to develop innovative, targeted therapies. In this second article of a two-part series, we'll discuss the competitive landscape in the SCS market, the key players, emerging companies and their respective technologies.

Neurology Market Intelligence

Venture Funding Deals, July 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced May through June.

BioPharmaceutical Medical Device

Device/Diagnostics Quarterly Deal Statistics, Q4 2015

At $1.2 billion, Q4 device financing was the second-lowest quarter of 2015; M&A dollar volume was also low, but included multiple deals across various cardiovascular markets. Diagnostics financing was also down in Q4, totaling $403 million; acquisitions were worth $441 million.

Medical Device Deals
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Services
  • Therapeutic Areas
  • Cardiovascular
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Greatbatch Inc.
  • Wilson Greatbatch Technologies Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Integer Holdings Corp.
  • Senior Management
  • Joseph W Dziedzic, Pres. & CEO
    Jeremy Friedman, EVP, COO & Interim CFO
    Tony Borowicz, VP, Strategy & Bus. Dev.
  • Contact Info
  • Integer Holdings Corp.
    Phone: (214) 618-5243
    2595 Dallas Pkwy., Ste. 310
    Frisco, TX 75034
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register